Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TachoSil® Versus Current Practice in Dura Sealing Techniques for the Prevention of Post-operative Cerebrospinal Fluid (CSF) Leaks in Patients Undergoing Skull Base Surgery: An Open Label, Randomised, Controlled, Multi-centre, Parallel Group Efficacy and Safety Trial.

NCT01355627 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01355627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TachoSil® Versus Current Practice in Dura Sealing Techniques for the Prevention of Post-operative Cerebrospinal Fluid (CSF) Leaks in Patients Undergoing Skull Base Surgery: An Open Label, Randomised, Controlled, Multi-centre, Parallel Group Efficacy and Safety Trial.
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2013
Enrollment
726 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrospinal fluid leaks